| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ.
Purpose: To compare the effects of a multimodal nonpharmacologic intervention to digoxin and to placebo in patients with congestive heart failure receiving background therapy with angiotensin-converting enzyme inhibitors.
Design: Randomized, parallel assignment to three treatment groups of 20 patients with congestive heart failure (New York Heart Association Class II and III).
Intervention: Nonpharmacologic treatment program included the following: (1) graduated exercise training, three to five times per week; (2) structured cognitive theraphy and stress management; and (3) dietary intervention aimed at salt reduction and weight reduction in the overweight. Digoxin was titrated to achieve a blood level between 0.8 and 2.0 ng/ml. Placebo and digoxin were administered in a randomized, double-blind fashion.
Results: Echocardiographic ejection fraction improved (p<0.05) in the digitalis group (change=+4.4±6.5) compared with both placebo (change=
1.2±3.9) and nonpharmacologic therapy (change=3.2±3.9). The nonpharmacologic treatment program was well tolerated by all patients and resulted in significant improvement (p<0.05) in exercise tolerance (digoxin=+51±50 s, placebo=+91±76, nonpharmacologic therapy=+182±139), as well as Beck Depression Inventory score (digoxin=+1.2±4.4, placebo=+2.0±4.2, nonpharmacologic therapy=5.0±4.2), Hamilton Scale scores of anxiety (digoxin=+3.0±6.8, placebo=+6.0±2.6, nondrug therapy=5.2±5.4), and depression (digoxin=+l.0±4.9, placebo=+5.0±5.0, nonpharmacologic therapy=6.6±10.1). In addition, weight loss was significantly greater with nonpharmacologic therapy (digoxin=+0.32±1.76 kg; placebo=1.35±1.44 kg; nonpharmacologic therapy=4.37±4.50 kg) compared with both digoxin and placebo.
Conclusions: Nonpharmacologic therapy improved functional capacity, body weight, and mood state in patients with congestive heart failure. In contrast, digoxin improved ejection fraction without corresponding changes in exercise tolerance or quality of life.
Key Words: cognitive therapy • congestive heart failure • exercise • nonpharmacologic therapy
Submitted on January 7, 1994
Accepted on March 16, 2007
This article has been cited by other articles:
|
|
 |
|
  T. Rutledge, V. A. Reis, S. E. Linke, B. H. Greenberg, and P. J. Mills Depression in Heart Failure: A Meta-Analytic Review of Prevalence, Intervention Effects, and Associations With Clinical Outcomes J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1527 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L. Pina, C. S. Apstein, G. J. Balady, R. Belardinelli, B. R. Chaitman, B. D. Duscha, B. J. Fletcher, J. L. Fleg, J. N. Myers, and M. J. Sullivan Exercise and Heart Failure: A Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention Circulation, March 4, 2003; 107(8): 1210 - 1225. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Crowther, A. Maroulis, N. Shafer-Winter, and R. Hader Evidence-based development of a hospital based heart failure centre Evid. Based Nurs., January 1, 2003; 6(1): 4 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. A. MacMahon and G. Y. H. Lip Psychological Factors in Heart Failure: A Review of the Literature Arch Intern Med, March 11, 2002; 162(5): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.I Larsen, T Aarsland, M Kristiansen, A Haugland, and K Dickstein Assessing the effect of exercise training in men with heart failure. Comparison of maximal, submaximal and endurance exercise protocols Eur. Heart J., April 2, 2001; 22(8): 684 - 692. [Abstract] [PDF]
|
|
|
|
|
|
Recommendations for exercise training in chronic heart failure patients Eur. Heart J., January 2, 2001; 22(2): 125 - 135. [PDF]
|
|
|
|
 |
|
 R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Scientific Statement: AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association J. Nutr., January 1, 2001; 131(1): 132 - 146. [Full Text]
|
|
|
|
 |
|
 R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Stroke, November 1, 2000; 31(11): 2751 - 2766. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Krauss, R. H. Eckel, B. Howard, L. J. Appel, S. R. Daniels, R. J. Deckelbaum, J. W. Erdman Jr, P. Kris-Etherton, I. J. Goldberg, T. A. Kotchen, et al. AHA Dietary Guidelines : Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association Circulation, October 31, 2000; 102(18): 2284 - 2299. [Full Text] [PDF]
|
|
|
|
|
|
M. W. Rich and R. F. Nease Cost-effectiveness Analysis in Clinical Practice: The Case of Heart Failure Arch Intern Med, August 9, 1999; 159(15): 1690 - 1700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. ERHARDT and C. CLINE Heart failure clinics: a possible means of improving care Heart, November 1, 1998; 80(5): 428 - 429. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
